CLINICAL_TRIALS
trial_result
· 2022-11-08
Clinical Trial Update: A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE) [Phase 2]
Summary
Phase 2 trial of CSL312 in hereditary angioedema completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSL Behring | Conditions: Hereditary Angioedema | Phase 2 | Status: COMPLETED | Results posted: 2022-11-08